Gw Pharma ADR (GWPH)

218.96  -0.32 (-0.15%)

After market: 219.58 +0.62 (+0.28%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

Gw Pharma ADR

NASDAQ:GWPH (5/4/2021, 7:00:01 PM)

After market: 219.58 +0.62 (+0.28%)

218.96

-0.32 (-0.15%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap6.86B
Shares
PEN/A
Fwd PE326.81
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

GWPH Daily chart

Company Profile

GW Pharmaceuticals plc is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, Sativex is used for the treatment of MS symptoms, cancer pain, and neuropathic pain. It operates primarily in the United Kingdom, Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc is based in Salisbury, the United Kingdom.

Company Info

Gw Pharma ADR

SOVEREIGN HOUSE VISION PARK HISTON

CAMBRIDGE X0 CB24 9BZ

P: 44-12-2326-6800

CEO: Justin Gover

GWPH News

News Image3 years ago - BloombergSnoop Dogg-Backed Oxford Cannabinoid Fluctuates in Stock Debut

Oxford Cannabinoid Technologies, which counts tobacco giant Imperial Brands Plc and rapper Snoop Dogg among its investors, swung between big gains and losses as it debuted on the London Stock Exchange.

News Image3 years ago - BloombergSnoop Dogg-Backed Oxford Cannabinoid Fluctuates in Debut

Oxford Cannabinoid Technologies, the U.K. prescription drug company that counts rapper Snoop Dogg among its investors, swung wildly between gains and losses on its London stock-market debut, capping a volatile week for investors.

News Image3 years ago - BloombergSnoop Dogg-Backed Pharma Firm Oxford Cannabinoid to List in U.K.

Oxford Cannabinoid Technologies, which counts tobacco giant Imperial Brands Plc and rapper Snoop Dogg among its investors, is set to start trading Friday on the London Stock Exchange.

News Image3 years ago - Investor's Business DailyMedical Stocks Jazz, Horizon Are Accelerating But Iqvia Is Hitting The Brakes

Jazz Pharmaceuticals and Horizon Therapeutics are among a cadre of accelerating medical stocks, while big names like Iqvia Holdings are hitting the brakes.

News Image3 years ago - FinancialNewsMediaCBD Oil Extract Market Share Projected To Reach $25.57 Billion by 2027

GWPH Twits

Here you can normally see the latest stock twits on GWPH, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example